Liquid Biopsy Promotes Precision Medicine By Tracking Patient’s Cancer

Published on Nov 4, 2015

In a study published in Nature Communications, Dr. Muhammed Murtaza, who holds a joint appointment at Mayo Clinic and Translational Genomics Research Institute (TGEN), and colleagues, describe an extensive comparison between biopsy results and analysis of ctDNA in a patient with breast cancer.

In the following video, Dr. Murtaza describes how circulating tumor DNA in blood could inform physicians on best treatments for individual patients.

For more information, visit:
►Mayo Clinic Center for Individualized Medicine: http://mayoresearch.mayo.edu/center-f…
►TGEN: https://tgen.org/home/news/2015-media…